Allscripts (MDRX) Tops Q3 EPS by 5c; Withdrawing Guidance; to Evaluate Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Piper Jaffray Downgrades Allscripts (MDRX) to Underweight
November 9, 2012 6:54 AM ESTPiper Jaffray downgraded Allscripts (NASDAQ: MDRX) from Neutral to Underweight with a price target of $7.00 (from $12.00) following Q3 results and announcement that it will explore alternatives.
For an analyst ratings summary and ratings history on Allscripts... More
Allscripts-Misys (MDRX) Resumes, Shares Higher in Late Trading
November 8, 2012 4:40 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) resumes trading with the stock up over 7 percent in the late session Thursday.... More
Allscripts-Misys Healthcare Solution (MDRX) halted, news pending
November 8, 2012 4:02 PM ESTAllscripts-Misys Healthcare Solution (NASDAQ: MDRX) halted, news pending... More
